Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Head-to-head comparison of relative cerebral blood flow derived from dynamic [18F]florbetapir and [18F]flortaucipir PET in subjects with subjective cognitive decline

    Dynamic PET imaging studies provide accurate estimates of specific binding, but also measure the relative tracer delivery (R1), which is a proxy for relative cerebral blood flow (rCBF). Recently, studies suggeste...

    Hayel Tuncel, Denise Visser, Tessa Timmers, Emma E. Wolters in EJNMMI Research (2023)

  2. Article

    Open Access

    Sensitivity of an AI method for [18F]FDG PET/CT outcome prediction of diffuse large B-cell lymphoma patients to image reconstruction protocols

    Convolutional neural networks (CNNs), applied to baseline [18F]-FDG PET/CT maximum intensity projections (MIPs), show potential for treatment outcome prediction in diffuse large B-cell lymphoma (DLBCL). The aim o...

    Maria C. Ferrández, Sandeep S. V. Golla, Jakoba J. Eertink in EJNMMI Research (2023)

  3. Article

    Open Access

    An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients

    Convolutional neural networks (CNNs) may improve response prediction in diffuse large B-cell lymphoma (DLBCL). The aim of this study was to investigate the feasibility of a CNN using maximum intensity projecti...

    Maria C. Ferrández, Sandeep S. V. Golla, Jakoba J. Eertink in Scientific Reports (2023)

  4. Article

    Open Access

    Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex

    Behavioural symptoms and frontotemporal hypometabolism overlap between behavioural variant of frontotemporal dementia (bvFTD) and primary psychiatric disorders (PPD), hampering diagnostic distinction. Voxel-wi...

    Marie-Paule E. van Engelen, Sander C. J. Verfaillie, Annemieke Dols in EJNMMI Research (2023)

  5. Article

    Open Access

    Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study

    Tau pathology is associated with concurrent atrophy and decreased cerebral blood flow (CBF) in Alzheimer’s disease (AD), but less is known about their temporal relationships. Our aim was therefore to investiga...

    Denise Visser, Sander C. J. Verfaillie in European Journal of Nuclear Medicine and M… (2023)

  6. Article

    Open Access

    Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods

    [18F]FDG PET-based metabolic tumor volume (MTV) is a promising prognostic marker for lymphoma patients. The aim of this study is to assess the sensitivity of several MTV segmentation methods to variations in imag...

    Maria C. Ferrández, Jakoba J. Eertink, Sandeep S. V. Golla in EJNMMI Research (2022)

  7. Article

    Open Access

    Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease

    Early-onset Alzheimer’s disease (EOAD) and late-onset Alzheimer’s disease (LOAD) differ in neuropathological burden and type of cognitive deficits. Assessing tau pathology and relative cerebral blood flow (rCB...

    Denise Visser, Sander C. J. Verfaillie in European Journal of Nuclear Medicine and M… (2022)

  8. Article

    Open Access

    Validation and test–retest repeatability performance of parametric methods for [11C]UCB-J PET

    [11C]UCB-J is a PET radioligand that binds to the presynaptic vesicle glycoprotein 2A. Therefore, [11C]UCB-J PET may serve as an in vivo marker of synaptic integrity. The main objective of this study was to evalu...

    Hayel Tuncel, Ronald Boellaard, Emma M. Coomans in EJNMMI Research (2022)

  9. Article

    Open Access

    Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [18F]Flortaucipir and [18F]Florbetapir Brain PET Studies

    The simplified reference tissue model (SRTM) is commonly applied for the quantification of brain positron emission tomography (PET) studies, particularly because it avoids arterial cannulation. SRTM requires a...

    Bart M. de Vries, Tessa Timmers, Emma E. Wolters in Molecular Imaging and Biology (2021)

  10. Article

    Open Access

    Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F]Flortaucipir Studies

    Dynamic positron emission tomography (PET) protocols allow for accurate quantification of [18F]flortaucipir-specific binding. However, dynamic acquisitions can be challenging given the long required scan duration...

    Hayel Tuncel, Denise Visser, Maqsood Yaqub, Tessa Timmers in Molecular Imaging and Biology (2021)

  11. Article

    Open Access

    Classification of negative and positive 18F-florbetapir brain PET studies in subjective cognitive decline patients using a convolutional neural network

    Visual reading of 18F-florbetapir positron emission tomography (PET) scans is used in the diagnostic process of patients with cognitive disorders for assessment of amyloid-ß (Aß) depositions. However, this can be...

    Bart Marius de Vries, Sandeep S. V. Golla in European Journal of Nuclear Medicine and M… (2021)

  12. Article

    Open Access

    In vivo tau pathology is associated with synaptic loss and altered synaptic function

    The mechanism of synaptic loss in Alzheimer’s disease is poorly understood and may be associated with tau pathology. In this combined positron emission tomography (PET) and magnetoencephalography (MEG) study, ...

    Emma M. Coomans, Deborah N. Schoonhoven, Hayel Tuncel in Alzheimer's Research & Therapy (2021)

  13. Article

    Correction to: Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease

    The authors regret to inform readers that the following error was detected in the original article. The values for entorhinal, limbic and neortical SUVr were switched between SCD Aβ + and Aβ- in Table 1 and ha...

    Emma E. Wolters, Rik Ossenkoppele in European Journal of Nuclear Medicine and M… (2020)

  14. Article

    Open Access

    Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease

    In vivo Alzheimer’s disease (AD) biomarkers for tau pathology are cerebrospinal fluid (CSF) phosphorylated tau (p-tau) and [18F]flortaucipir positron emission tomography (PET). Our aim was to assess associations ...

    Emma E. Wolters, Rik Ossenkoppele in European Journal of Nuclear Medicine and M… (2020)

  15. Article

    Open Access

    The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study

    The novel PET tracer [11C]SMW139 binds with high affinity to the P2X7 receptor, which is expressed on pro-inflammatory microglia. The purposes of this first in-man study were to characterise pharmacokinetics of [

    Marloes H. J. Hagens, Sandeep S. V. Golla in European Journal of Nuclear Medicine and M… (2020)

  16. Article

    Open Access

    Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

    Neuropathological studies have linked tau aggregates to neuronal loss. To describe the spatial distribution of neurofibrillary tangle pathology in post-mortem tissue, Braak staging has been used. The aim of th...

    Tessa Timmers, Rik Ossenkoppele, Emma E. Wolters in Alzheimer's Research & Therapy (2019)

  17. Article

    Open Access

    A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus

    Off-target binding in the choroid plexus (CP) may cause spill-in of the tau PET tracer [18F] flortaucipir into the adjacent hippocampus region. The impact of this spill-in on hippocampal uptake was assessed using...

    Emma E. Wolters, Sandeep S. V. Golla, Tessa Timmers, Rik Ossenkoppele in EJNMMI Research (2018)

  18. Article

    Open Access

    First in human evaluation of [18F]PK-209, a PET ligand for the ion channel binding site of NMDA receptors

    Efforts to develop suitable positron emission tomography (PET) tracers for the ion channel site of human N-methyl-d-aspartate (NMDA) receptors have had limited success. [18F]PK-209 is a GMOM derivative that binds...

    Jasper van der Aart, Sandeep S. V. Golla, Marieke van der Pluijm in EJNMMI Research (2018)

  19. Article

    Open Access

    Model selection criteria for dynamic brain PET studies

     Several criteria exist to identify the optimal model for quantification of tracer kinetics. The purpose of this study was to evaluate the correspondence in kinetic model preference identification for brain PE...

    Sandeep S. V. Golla, Sofie M. Adriaanse, Maqsood Yaqub in EJNMMI Physics (2017)

  20. Article

    Open Access

    Quantification of Tau Load Using [18F]AV1451 PET

    The tau tracer [18F]AV1451, also known as flortaucipir, is a promising ligand for imaging tau accumulation in Alzheimer’s disease (AD). Most of the previous studies have quantified tau load using standardized upt...

    Sandeep S. V. Golla, Tessa Timmers, Rik Ossenkoppele in Molecular Imaging and Biology (2017)

previous disabled Page of 2